|Probable phosphatidylethanolamine transferase Mcr-1|
The mobilized colistin resistance (mcr) gene confers plasmid-mediated resistance to colistin, one of a number of last-resort antibiotics for treating Gram-negative infections. mcr-1, the original variant, is capable of horizontal transfer between different strains of a bacterial species. After discovery in November 2015 in E. coli (strain SHP45) from a pig in China it has been found in Escherichia coli, Salmonella enterica, Klebsiella pneumoniae, Enterobacter aerogenes, and Enterobacter cloacae. As of 2017[update], it has been detected in more than 30 countries on 5 continents in less than a year.
The "mobilized colistin resistance" (mcr-1) gene confers plasmid-mediated resistance to colistin, a polymyxin and one of a number of last-resort antibiotics for treating infections. The gene is found in no less than ten species of the Enterobacteriaceae: Escherichia coli, Salmonella, Klebsiella pneumoniae, Enterobacter aerogenes, Enterobacter cloacae, Cronobacter sakazakii, Shigella sonnei, Kluyvera species, Citrobacter species, and Raoultella ornithinolytica.
The mechanism of resistance of the MCR gene is a phosphatidylethanolamine transferase. The enzyme transfers a phosphoethanolamine residue to the lipid A present in the cell membrane of gram-negative bacteria. The altered lipid A has much lower affinity for colistin and related polymyxins resulting in reduced activity of the antimicrobial. This type of resistance is known as target modification. Although the same mechanism has been observed before with enzymes like eptA, mcr-1 is the first polymyxin resistance gene known to be capable of horizontal transfer between different strains of a bacterial species.
Discovery and geographical spread
The gene was first discovered in E. coli (strain SHP45) from a pig in China April 2011 and published in November 2015. It was identified by independent researchers in human samples from Malaysia, China, England, Scotland, and the United States.
In April 2016, a 49-year-old woman sought medical care at a Pennsylvania clinic for UTI symptoms. PCR of an E. coli isolate cultured from her urine revealed the mcr-1 gene for the first time in the United States, and the CDC sent an alert to health care facilities. In the following twelve months, four additional people were reported to have infections with mcr-1 carrying bacteria.
As of February 2017[update] mcr-1 has been detected in more than 30 countries on 5 continents in less than a year, and it appears to be spreading in hospitals in China. The prevalence in five Chinese provinces between April 2011 and November 2014 was 15% in raw meat samples and 21% in food animals during 2011–14, and 1% in people hospitalized with infection.
Given the importance of mcr-1 in enabling bacteria to acquire polymyxin resistance, MCR-1 (the protein that is encoded by mcr-1) is a current inhibition target for the development of new antibiotics. For example, ethylenediaminetetraacetic acid, a metal-chelating agent, was shown to inhibit MCR-1 as it is a zinc-dependent enzyme. Substrate analogues, such as ethanolamine and glucose, were also shown to inhibit MCR-1. The use of a combined antibiotics regime has shown to be able to overcome the resistance that is caused by mcr-1, although the mechanism of action may not be directly targeting the MCR-1 protein.
Other mcr genes
As of May 2019[update], nine mobilized colistin resistance genes termed mcr-1 through mcr-9 has been identified. They are homologous to each other, and work in similar ways. The mcr-2 gene is a rare variant of mcr-1 and is found only in Belgium. The less-related mcr-3, mcr-4, and mcr-5 were identified in E. coli and Salmonella.
- Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, Doi Y, Tian G, Dong B, Huang X, Yu LF, Gu D, Ren H, Chen X, Lv L, He D, Zhou H, Liang Z, Liu JH, Shen J (February 2016). "Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study". The Lancet. Infectious Diseases. 16 (2): 161–8. doi:10.1016/S1473-3099(15)00424-7. PMID 26603172.
- Reardon, Sara (21 December 2015). "Spread of antibiotic-resistance gene does not spell bacterial apocalypse — yet". Nature. doi:10.1038/nature.2015.19037.
- Hinchliffe P, Yang QE, Portal E, Young T, Li H, Tooke CL, Carvalho MJ, Paterson NG, Brem J, Niumsup PR, Tansawai U, Lei L, Li M, Shen Z, Wang Y, Schofield CJ, Mulholland AJ, Shen J, Fey N, Walsh TR, Spencer J (January 2017). "Insights into the Mechanistic Basis of Plasmid-Mediated Colistin Resistance from Crystal Structures of the Catalytic Domain of MCR-1". Scientific Reports. 7: 39392. Bibcode:2017NatSR...739392H. doi:10.1038/srep39392. PMC 5216409. PMID 28059088.
- Anandan A, Evans GL, Condic-Jurkic K, O'Mara ML, John CM, Phillips NJ, Jarvis GA, Wills SS, Stubbs KA, Moraes I, Kahler CM, Vrielink A (February 2017). "Structure of a lipid A phosphoethanolamine transferase suggests how conformational changes govern substrate binding". Proceedings of the National Academy of Sciences of the United States of America. 114 (9): 2218–2223. doi:10.1073/pnas.1612927114. PMC 5338521. PMID 28193899.
- "Newly Reported Gene, mcr-1, Threatens Last-Resort Antibiotics". Antibiotic/Antimicrobial Resistance: AR Solutions in Action. Centers for Disease Control and Prevention. 30 November 2016.
- Gao R, Hu Y, Li Z, Sun J, Wang Q, Lin J, Ye H, Liu F, Srinivas S, Li D, Zhu B, Liu YH, Tian GB, Feng Y (November 2016). "Dissemination and Mechanism for the MCR-1 Colistin Resistance". PLoS Pathogens. 12 (11): e1005957. doi:10.1371/journal.ppat.1005957. PMC 5125707. PMID 27893854.
- Schnirring, Lisa (18 December 2015). "More MCR-1 findings lead to calls to ban ag use of colistin". CIDRAP News. CIDRAP — Center for Infectious Disease Research and Policy. Retrieved 2015-12-22.
- McKenna, Maryn. "Apocalypse Pig Redux: Last-Resort Resistance in Europe". Phenomena. Retrieved 28 May 2016.
- "Antibiotic-resistant bacteria detected in Scotland". BBC News. 2016-08-03. Retrieved 2017-03-29.
- The U.S. Military HIV Research Program (MHRP). "First discovery in United States of colistin resistance in a human E. coli infection". ScienceDaily. Retrieved 2016-05-27.
- Wappes, Jim (26 May 2016). "Highly resistant MCR-1 'superbug' found in US for first time". CIDRAP News. CIDRAP — Center for Infectious Disease Research and Policy. Retrieved 2016-08-09.
- "Tracking mcr-1". Antibiotic/Antimicrobial Resistance: Biggest Threats. Centers for Disease Control and Prevention. 24 February 2017.
- Yi L, Wang J, Gao Y, Liu Y, Doi Y, Wu R, Zeng Z, Liang Z, Liu JH (February 2017). "mcr-1-Harboring Salmonella enterica Serovar Typhimurium Sequence Type 34 in Pigs, China". Emerging Infectious Diseases. 23 (2): 291–295. doi:10.3201/eid2302.161543. PMC 5324782. PMID 28098547.
- Dall, Chris (27 January 2017). "Studies show spread of MCR-1 gene in China". CIDRAP News. CIDRAP — Center for Infectious Disease Research and Policy.
- Nield, David. "A Dangerous Antibiotic-Resistant Gene Has Spread The World. We Now Know Where It Started". ScienceAlert. Retrieved 2018-04-02.
- Wang R, van Dorp L, Shaw LP, Bradley P, Wang Q, Wang X, Jin L, Zhang Q, Liu Y, Rieux A, Dorai-Schneiders T, Weinert LA, Iqbal Z, Didelot X, Wang H, Balloux F (March 2018). "The global distribution and spread of the mobilized colistin resistance gene mcr-1". Nature Communications. 9 (1): 1179. Bibcode:2018NatCo...9.1179W. doi:10.1038/s41467-018-03205-z. PMC 5862964. PMID 29563494.
- Son SJ, Huang R, Squire CJ, Leung IK (January 2019). "MCR-1: a promising target for structure-based design of inhibitors to tackle polymyxin resistance". Drug Discovery Today. 24 (1): 206–216. doi:10.1016/j.drudis.2018.07.004. PMID 30036574.
- Wei P, Song G, Shi M, Zhou Y, Liu Y, Lei J, Chen P, Yin L (February 2018). "Substrate analog interaction with MCR-1 offers insight into the rising threat of the plasmid-mediated transferable colistin resistance". FASEB Journal. 32 (2): 1085–1098. doi:10.1096/fj.201700705R. PMID 29079699.
- MacNair CR, Stokes JM, Carfrae LA, Fiebig-Comyn AA, Coombes BK, Mulvey MR, Brown ED (January 2018). "Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics". Nature Communications. 9 (1): 458. Bibcode:2018NatCo...9..458M. doi:10.1038/s41467-018-02875-z. PMC 5792607. PMID 29386620.
- Carroll LM, Gaballa A, Guldimann C, Sullivan G, Henderson LO, Wiedmann M (May 2019). "Identification of Novel Mobilized Colistin Resistance Gene mcr-9 in a Multidrug-Resistant, Colistin-Susceptible Salmonella enterica Serotype Typhimurium Isolate". mBio. 10 (3): e00853–19. doi:10.1128/mBio.00853-19. PMC 6509194. PMID 31064835.
- Sun J, Zhang H, Liu YH, Feng Y (September 2018). "Towards Understanding MCR-like Colistin Resistance". Trends in Microbiology. 26 (9): 794–808. doi:10.1016/j.tim.2018.02.006. PMID 29525421.
- Xu Y, Wei W, Lei S, Lin J, Srinivas S, Feng Y (April 2018). "An Evolutionarily Conserved Mechanism for Intrinsic and Transferable Polymyxin Resistance". mBio. 9 (2). doi:10.1128/mBio.02317-17. PMC 5893884. PMID 29636432.